Press release
Key Players and Competitive Overview in the Antibody Drug Conjugates Contract Manufacturing Market
Antibody Drug Conjugates Contract Manufacturing
Projected Growth Trajectory of the Antibody Drug Conjugates Contract Manufacturing Market
The market size for antibody drug conjugates contract manufacturing is projected to reach $15.37 billion by 2029, growing at a strong compound annual growth rate (CAGR) of 9.9%. This surge is fueled by the expanding role of personalized medicine, broadening applications of ADCs beyond oncology, increasing partnerships between biotech and pharmaceutical companies, heightened use of ADCs in clinical trials, and a focus on cost-efficient manufacturing processes. Key trends expected to influence the market in the forecast period include advancements in biomarker discovery, biotechnology innovations, adoption of next-generation ADC technologies, improvements in linker and payload design, and the integration of artificial intelligence to support drug development.
Download a free sample of the antibody drug conjugates contract manufacturing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18954&type=smp
Dominant Players in the Antibody Drug Conjugates Contract Manufacturing Industry
Several leading companies are prominent within the ADC contract manufacturing market. These include AbbVie Inc., Eli Lilly and Company, Gilead Sciences Inc., Merck KGaA, Boehringer Ingelheim, Recipharm AB, Sigma-Aldrich, Sartorius AG, Curia, Lonza Group AG, Catalent Inc., KBI Biopharma, Alcami Corporation, Formosa Laboratories, BioVectra Inc., Axplora, Abzena PLC, ImmunoGen Inc., EirGenix Inc., Avid Bioservices Inc., Mersana Therapeutics, Cerbios-Pharma SA, Creative Biolabs, Aurigene Pharmaceutical Services Ltd., and Sterling Pharma Solutions.
Significant Industry Acquisition Enhancing Capabilities
In March 2024, Johnson & Johnson, the US pharmaceutical and biotechnology giant, completed its acquisition of Ambrx Biopharma Inc. for $2.0 billion. This strategic move aims to strengthen Johnson & Johnson's pipeline of advanced therapies by incorporating Ambrx's cutting-edge drug development technologies and expanding its biologics and targeted treatment options. Ambrx Biopharma, based in the US, specializes in developing innovative therapies, including antibody-drug conjugates.
View the full antibody drug conjugates contract manufacturing market report:
https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-contract-manufacturing-global-market-report
Emerging Trends Driving Innovation in Antibody Drug Conjugates Manufacturing
Top companies in the ADC contract manufacturing space are increasingly focusing on novel product developments, such as single-use reactors, to boost manufacturing flexibility, minimize contamination risks, and simplify production workflows. These reactors are transforming ADC manufacturing by offering adaptable, efficient, and contamination-free solutions, which are critical for producing these complex biologics.
For example, in September 2024, MilliporeSigma, a US-based life sciences firm, launched the Mobius ADC Reactor, a single-use system specifically engineered for ADC production. This reactor incorporates advanced mixing and control technologies that improve conjugation processes, scalability, and product consistency. The Mobius ADC Reactor facilitates higher yields and enhanced quality control, addressing the rising demand for targeted cancer therapies that deliver improved safety and efficacy.
Detailed Segmentation of the Global Antibody Drug Conjugates Contract Manufacturing Market
This report segments the ADC contract manufacturing market by:
1) Type: Immunoglobulin G1 (IgG1), Immunoglobulin G4 (IgG4)
2) Linker: Cleavable Linker, Non-Cleavable Linker
3) Condition Treated: Myeloma, Lymphoma, Breast Cancer, Other Conditions
4) Phase of Development: Clinical, Commercial
These categories provide a nuanced understanding of the market's structure and the different factors influencing its growth across various stages and applications.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Players and Competitive Overview in the Antibody Drug Conjugates Contract Manufacturing Market here
News-ID: 4318890 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for ADC
ADC Market: Transforming Cancer Treatment
The global market for antibody-drug conjugates (ADCs) was valued at US$ 11.32 billion in 2023 and is expected to reach US$ 27.37 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.23% from 2024 to 2033. This growth is primarily driven by the increasing prevalence of cancer and the growing demand for safe and effective treatments.
Antibody Drug Conjugates: A Growing Force in Cancer Treatment and Market Expansion
Key…
With Knockout ADC Innovations, Creative Biolabs Took Center Stage at the 2024 Wo …
Creative Biolabs wrapped up a successful show at the 15th Annual World ADC San Diego in the beginning of November, where its third year of participation, highlighting its dedication to the advancement of antibody-drug conjugate (ADC) technology.
New York, USA - November 13, 2024 - Creative Biolabs seized the spotlight at Booth 313 by offering groundbreaking solutions across the entire ADC development spectrum, which demonstrate their unrivaled expertise and dedication to…
Showing Off Their ADC Game: Creative Biolabs Hits the 15th Annual World ADC Summ …
From November 4, Creative Biolabs will be back at the 15th Annual World ADC Summit in San Diego, marking its fourth year at the leading global gathering featuring innovative conjugates.
New York, USA - November 6, 2024 - Creative Biolabs invites all ADC enthusiasts, from new entrants to seasoned experts, to explore its comprehensive suite of ADC solutions and experience the latest in antibody-drug conjugate (ADC) innovation at Booth #313.
Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg
"2023…
ADC Drugs For Breast Cancer Treatment
Breast cancer is the malignant tumor with the highest morbidity and mortality among women worldwide. At present, the main therapeutic methods include surgery, chemotherapy, radiotherapy, endocrine therapy and targeted therapy, etc. The development and marketing of new drugs have far-reaching significance in improving the survival of breast cancer patients and changing the pattern of breast cancer treatment.
On February 24, 2023, The NMPA approved Enhertu, an injectable drug developed jointly by…
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Succe …
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Successive Approximation ADC, Delta-sigma ADC, and Others (Pipelined/Flash ADC)), and Application (Consumer Electronics and Industrial) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Full Report : https://www.alliedmarketresearch.com/analog-to-digital-converters-market
Increasing disposable income and technological advancements supplement the analog-to-digital converters market. However, complex design of the ADC hampers this market growth. On the other hand, encouragement in digitization of work processes by government in emerging economies,…
Global Data Converters Market Report 2017 (Analog to Digital Converter, Current …
The research report titled Global Data Converters Sales Market Report 2017 market size and forecast and overview on current market trends.
This report studies sales (consumption) of Global Data Converters Market 2017, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
National Semiconductor
Nippon Precision Circuits Inc
Micro Analog systems
Microchip Technology.
TelCom Semiconductor, Inc
Vishay Siliconix
Texas…
